This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Atrial Fibrillation
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The proposed study is designed to evaluate the effect of an intravenous infusion of magnesium sulfate in facilitating successful cardioversion of atrial fibrillation and in decreasing the energy threshold (in J) required for successful cardioversion of atrial fibrillation into sinus rhythm.

Provided treatments

  • Drug: Magnesium Sulfate
  • Other: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01597557. The sponsor of the trial is State University of New York at Buffalo and it is looking for 256 volunteers for the current phase.
Official trial title:
Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial